Liabilities and Equity in USD of Boundless Bio, Inc. from Q4 2023 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Boundless Bio, Inc. quarterly Liabilities and Equity history and change rate from Q4 2023 to Q3 2025.
Boundless Bio, Inc. Liabilities and Equity for the quarter ending 30 Sep 2025 was $169M, a 3.64% decline year-over-year.

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Change (%)

Boundless Bio, Inc. Quarterly Liabilities and Equity (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$169M	-$6.37M	-3.64%	30 Sep 2025	10-Q	05 Nov 2025
Q2 2025	$179M	-$8.75M	-4.65%	30 Jun 2025	10-Q	05 Aug 2025
Q1 2025	$191M	+$74.2M	+63.3%	31 Mar 2025	10-Q	09 May 2025
Q4 2024	$206M	+$76.5M	+58.9%	31 Dec 2024	10-Q	05 Nov 2025
Q3 2024	$175M			30 Sep 2024	10-Q	07 Nov 2024
Q2 2024	$188M			30 Jun 2024	10-Q	12 Aug 2024
Q1 2024	$117M			31 Mar 2024	10-Q	13 May 2024
Q4 2023	$130M			31 Dec 2023	10-K	27 Mar 2025

* An asterisk sign (*) next to the value indicates that the value is likely invalid.